PURPOSE: To evaluate the initial respiratory impairments [pulmonary functions and arterial blood gases (ABGs)] in patients with amyotrophic lateral sclerosis (ALS) according to Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R) at the time of admission. METHOD: Forty-five patients with ALS were evaluated between January 2004 and December 2007 by pulmonary function tests (PFTs) and ABG results at the time of admission. ALSFRS-R was used to quantify the severity of ALS patients. ALS patients were divided into 2 subgroups according to their ALSFRS-R scores as equal or below 26 (group 1, moderate-severe) and above 26 (group 2, mild). PFTs and ABG results were compared between these 2 subgroups. RESULTS: As 13 of the 45 pat...
IMPORTANCE The prognostic value of slow vital capacity (SVC) in relation to respiratory function dec...
<p>The relaxation rates and contractile properties of inspiratory muscles are altered with inspirato...
Amyotrophic lateral sclerosis (ALS) is a progressive, unrelenting and presently incurable neurodegen...
Background and purpose Respiratory insufficiency and its complications are the main cause of death i...
Background. Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder affectin...
© 2022 Elsevier B.V. All rights reserved.Background: Pulmonary function tests are routinely used to ...
Objective: Amyotrophic lateral sclerosis (ALS) is a progressive neuromuscular disease that causes sk...
Contains fulltext : 176941.pdf (publisher's version ) (Open Access)BACKGROUND: Non...
The rapidity of progression of amyotrophic lateral sclerosis (ALS) to death or respiratory failure i...
Objective: To examine whether the responses to standard dyspnea questionnaires and a new functional ...
The aim of this study was to evaluate the time course of breathing pattern and respiratory mechanics...
Introduction: Respiratory function is a critical predictor of survival in amyotrophic lateral sclero...
*<p>Defined as the presence of a hypoxic period (SpO<sub>2</sub><95%) for >10% of the total sleep ti...
© 2014 Informa HealthcareClinical assessment of the respiratory function is critical in amyotrophic ...
Introduction Respiratory failure is the leading cause of death in amyotrophic lateral sclerosis (A...
IMPORTANCE The prognostic value of slow vital capacity (SVC) in relation to respiratory function dec...
<p>The relaxation rates and contractile properties of inspiratory muscles are altered with inspirato...
Amyotrophic lateral sclerosis (ALS) is a progressive, unrelenting and presently incurable neurodegen...
Background and purpose Respiratory insufficiency and its complications are the main cause of death i...
Background. Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder affectin...
© 2022 Elsevier B.V. All rights reserved.Background: Pulmonary function tests are routinely used to ...
Objective: Amyotrophic lateral sclerosis (ALS) is a progressive neuromuscular disease that causes sk...
Contains fulltext : 176941.pdf (publisher's version ) (Open Access)BACKGROUND: Non...
The rapidity of progression of amyotrophic lateral sclerosis (ALS) to death or respiratory failure i...
Objective: To examine whether the responses to standard dyspnea questionnaires and a new functional ...
The aim of this study was to evaluate the time course of breathing pattern and respiratory mechanics...
Introduction: Respiratory function is a critical predictor of survival in amyotrophic lateral sclero...
*<p>Defined as the presence of a hypoxic period (SpO<sub>2</sub><95%) for >10% of the total sleep ti...
© 2014 Informa HealthcareClinical assessment of the respiratory function is critical in amyotrophic ...
Introduction Respiratory failure is the leading cause of death in amyotrophic lateral sclerosis (A...
IMPORTANCE The prognostic value of slow vital capacity (SVC) in relation to respiratory function dec...
<p>The relaxation rates and contractile properties of inspiratory muscles are altered with inspirato...
Amyotrophic lateral sclerosis (ALS) is a progressive, unrelenting and presently incurable neurodegen...